MicroRNA-375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signaling pathway

Zhou,Jian; Song,Shiduo; He,Songbing; Zhu,Xinguo; Zhang,Yi; Yi,Bin; Zhang,Bing; Qin,Gongzhao; Li,Dechun

doi:10.3892/ijmm.2014.1638

MicroRNA-375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signaling pathway

Authors:
- Jian Zhou
- Shiduo Song
- Songbing He
- Xinguo Zhu
- Yi Zhang
- Bin Yi
- Bing Zhang
- Gongzhao Qin
- Dechun Li
View Affiliations

Affiliations: Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China, Department of Nuclear Medicine, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China, Department of Gynaecology and Obstetrics, Suzhou Municipal Hospital, Suzhou, Jiangsu 215003, P.R. China
Published online on: January 28, 2014 https://doi.org/10.3892/ijmm.2014.1638
Pages: 950-956

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNAs (miRNAs or miRs) are believed to have great potential for use as molecular targets in the diagnosis and treatment of cancer. In this study, we demonstrate that miR-375 is downregulated in pancreatic carcinoma (PC) tissues and PC cell lines. We found that miR-375 negatively regulates the expression of 3-phosphoinositide-dependent protein kinase 1 (PDK1) by directly targeting the 3'UTR of the PDK1 transcript. To investigate the biological roles and the potential mechanisms of action of miR‑375, we induced either the up- or downregulation of miR-375 expression by transfecting various PC cells with miR-375 mimics or an inhibitor. Our results revealed that the upregulation of miR-375 inhibited cell growth and induced cell apoptosis, while the downregulation of miR-375 with the inhibitor had the opposite effect. In addition, our data demonstrate that miR-375 suppresses the malignant behavior of PC cells through the Akt signaling pathway rather than mitogen-activated protein kinase (MAPK) signaling pathways. Taken together, our findings indicate that targeting miR-375 by a genetic approach may provide a novel strategy for the treatment of PC.

View Figures

View References

1	Chen X, Ma S and Zhang Z: Analysis of clinical characteristics of pancreatic carcinoma in northern China. Pancreas. 39:1116–1118. 2010. View Article : Google Scholar : PubMed/NCBI
2	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
3	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
4	Vincent A, Herman J, Schulick R, Hruban RH and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011. View Article : Google Scholar
5	Ruan K, Fang X and Ouyang G: microRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett. 285:116–126. 2009. View Article : Google Scholar : PubMed/NCBI
6	Hrašovec S and Glavač D: microRNAs as Novel Biomarkers in Colorectal Cancer. Front Genet. 3:1802012.
7	Chen PS, Su JL and Hung MC: Dysregulation of microRNAs in cancer. J Biomed Sci. 19:902012. View Article : Google Scholar : PubMed/NCBI
8	Liu H: microRNAs in breast cancer initiation and progression. Cell Mol Life Sci. 69:3587–3599. 2012. View Article : Google Scholar : PubMed/NCBI
9	Poy MN, Eliasson L, Krutzfeldt J, et al: A pancreatic islet-specific microRNA regulates insulin secretion. Nature. 432:226–230. 2004. View Article : Google Scholar : PubMed/NCBI
10	Zhang WH, Gui JH, Wang CZ, et al: The identification of miR-375 as a potential biomarker in distal gastric adenocarcinoma. Oncol Res. 20:139–147. 2012. View Article : Google Scholar : PubMed/NCBI
11	Chang Y, Yan W, He X, et al: miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. Gastroenterology. 143:177–187.8. 2012. View Article : Google Scholar : PubMed/NCBI
12	Dai X, Chiang Y, Wang Z, et al: Expression levels of microRNA-375 in colorectal carcinoma. Mol Med Rep. 5:1299–1304. 2012.PubMed/NCBI
13	Raimondi C and Falasca M: Targeting PDK1 in cancer. Curr Med Chem. 18:2763–2769. 2011. View Article : Google Scholar : PubMed/NCBI
14	Westmoreland JJ, Wang Q, Bouzaffour M, Baker SJ and Sosa-Pineda B: Pdk1 activity controls proliferation, survival, and growth of developing pancreatic cells. Dev Biol. 334:285–298. 2009. View Article : Google Scholar : PubMed/NCBI
15	Nikitina EG, Urazova LN and Stegny VN: microRNAs and human cancer. Exp Oncol. 34:2–8. 2012.
16	He XX, Chang Y, Meng FY, et al: microRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene. 31:3357–3369. 2012. View Article : Google Scholar : PubMed/NCBI
17	Tsukamoto Y, Nakada C, Noguchi T, et al: microRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res. 70:2339–2349. 2010. View Article : Google Scholar : PubMed/NCBI
18	Shen Y, Wang P, Li Y, et al: miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer. Br J Cancer. 109:92–99. 2013. View Article : Google Scholar : PubMed/NCBI
19	Garzon R, Calin GA and Croce CM: microRNAs in Cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar
20	Liu AM, Poon RT and Luk JM: microRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Commun. 394:623–627. 2010. View Article : Google Scholar : PubMed/NCBI
21	Li X, Lin R and Li J: Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer. Dig Dis Sci. 56:2849–2856. 2011. View Article : Google Scholar : PubMed/NCBI
22	Ding L, Xu Y, Zhang W, et al: MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res. 20:784–793. 2010. View Article : Google Scholar : PubMed/NCBI
23	Nishikawa E, Osada H, Okazaki Y, et al: miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. Cancer Res. 71:6165–6173. 2011. View Article : Google Scholar : PubMed/NCBI
24	Liu Y, Xing R, Zhang X, et al: miR-375 targets the p53 gene to regulate cellular response to ionizing radiation and etoposide in gastric cancer cells. DNA Repair (Amst). 12:741–750. 2013. View Article : Google Scholar : PubMed/NCBI
25	Sheppard K, Kinross KM, Solomon B, Pearson RB and Phillips WA: Targeting PI3 kinase/AKT/mTOR signaling in cancer. Crit Rev Oncog. 17:69–95. 2012. View Article : Google Scholar : PubMed/NCBI
26	Dhanasekaran DN and Johnson GL: MAPKs: function, regulation, role in cancer and therapeutic targeting. Oncogene. 26:3097–3099. 2007. View Article : Google Scholar : PubMed/NCBI
27	Zhang X, Yan Z, Zhang J, et al: Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. Ann Oncol. 22:2257–2266. 2011. View Article : Google Scholar : PubMed/NCBI
28	Song J, Kim D, Chun CH and Jin EJ: microRNA-375, a new regulator of cadherin-7, suppresses the migration of chondrogenic progenitors. Cell Signal. 25:698–706. 2013. View Article : Google Scholar : PubMed/NCBI